Page 496 - IJB-10-2

International Journal of Bioprinting Bioprinted skin for testing of therapeutics

doi: 10.1136/bmj.321.7258.424 and precision medicine applications. Appl Phys Rev.
2019;6(1):011302.
30. Swain SL, Weinberg AD, English M, Huston G. IL-4 directs doi: 10.1063/1.5056188
the development of Th2-like helper effectors. J Immunol.
1990;145(11):3796-3806. 35. Mandrycky C, Wang Z, Kim K, Kim DH. 3D bioprinting
for engineering complex tissues. Biotechnol Adv. 2016;34(4):
31. Gaston RS, Deierhoi MH, Patterson T, et al. OKT3 first- 422-434.
dose reaction: association with T cell subsets and cytokine doi: 10.1016/j.biotechadv.2015.12.011
release. Kidney Int. 1991;39(1):141-148.
doi: 10.1038/ki.1991.18 36. Lee V, Singh G, Trasatti JP, et al. Design and fabrication of
human skin by three-dimensional bioprinting. Tissue Eng
32. Römer PS, Berr S, Avota E, et al. Preculture of PBMCs at Part C. 2014;20(6):473-484.
high cell density increases sensitivity of T-cell responses, doi: 10.1089/ten.TEC.2013.0335
revealing cytokine release by CD28 superagonist TGN1412.
Blood. 2011;118(26):6772-6782. 37. Michael S, Sorg H, Peck CT, et al. Tissue engineered skin
doi: 10.1182/blood-2010-12-319780 substitutes created by laser-assisted bioprinting form skin-
like structures in the dorsal skin fold chamber in mice. PLoS
33. Yoshizaki, K, Nishimoto N, Matsumoto K, et al. Interleukin One. 2013;8(3):e57741.
6 and expression of its receptor on epidermal keratinocytes. doi: 10.1371/journal.pone.0057741
Cytokine. 1990;2(5):381-387.
doi: 10.1016/1043-4666(90)90069-6 38. Weng T, Zhang W, Xia Y, et al. 3D bioprinting for skin tissue
engineering: current status and perspectives. J Tissue Eng.
34. Mazzocchi A, Soker S, Skardal A. 3D bioprinting for high- 2021;12:20417314211028574.
throughput screening: drug screening, disease modeling, doi: 10.1177/20417314211028574

Volume 10 Issue 2 (2024) 488 doi: 10.36922/ijb.1851